Q2 2013 Holdings
Filed 2013-08-08 | 10 holdings | $225.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| EpiZyme, Inc.(EPZMEUR) | Common | 29428V104 | $81.0K | 2,880,485 | 35.9% |
| Portola Pharmaceuticals, Inc. | Common | 737010108 | $60.0K | 2,441,344 | 26.6% |
| Verastem, Inc. | Common | 92337C104 | $24.1K | 1,736,171 | 10.7% |
| Pacira Pharmaceuticals, Inc.(PCRX) | Common | 695127100 | $23.9K | 824,255 | 10.6% |
| Kalobios Pharmaceuticals, Inc. | Common | 48344T100 | $14.9K | 2,632,928 | 6.6% |
| PharmAthene, Inc. | Common | 71714G102 | $10.1K | 6,347,614 | 4.5% |
| Aveo Pharmaceuticals, Inc.(AVEOEUR) | Common | 053588109 | $5.5K | 2,208,961 | 2.4% |
| Zalicus, Inc. | Common | 98887C105 | $3.1K | 5,566,980 | 1.4% |
| EnteroMedics, Inc. | Common | 29365M208 | $1.9K | 1,669,753 | 0.8% |
| Aratana Therapeutics Inc.(PETXEUR) | Common | 03874P101 | $1.4K | 180,505 | 0.6% |